A federal health agency’s updated guidance that’s aimed at helping physicians decide when PFAS-blood level tests are warranted doesn’t mention chemical concentrations that would justify specific additional tests doctors could use to identify illnesses associated with the chemicals.
The Centers for Disease Control and Prevention (CDC) released clinical guidance and a related fact sheet that it updated following advice it received in a report from the National Academies of Sciences, Engineering, and Medicine, the nation’s primary federal advisory institute.
The academies’ ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.